Lilly Supports Cialis Spontaneity With Internet Trial, Direct Patient Data

Lilly's program to create a "spontaneity" advantage for its erectile dysfunction drug Cialis includes a Phase IIIb trial with direct patient observation reports from an electronic reporting system developed by the California clinical trials firm, 1747, Inc

More from Archive

More from Pink Sheet